The results of flow cytometry showed that after the intervention of the GLP-1 receptor agonist liraglutide, the apoptosis (57.69 ± 9.21) of CRC cells increased and the difference was statistically significant (p < 0.05), as shown in Figure 4. The gene discussed is GLP1R; the disease is colorectal carcinoma.